XML 94 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Benefit Plans - RSU, RSA, and PSA Activities (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Oct. 26, 2023
Jul. 27, 2023
Apr. 25, 2023
Jan. 31, 2023
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Weighted Average Grant-Date Fair Value per Share                                      
Payments of cash dividends (in dollars per share) $ 0.22 $ 0.22 $ 0.22 $ 0.22 $ 0.22 $ 0.22 $ 0.22 $ 0.22 $ 0.21 $ 0.21 $ 0.21 $ 0.21 $ 0.20 $ 0.20 $ 0.20 $ 0.20 $ 0.88 $ 0.84 $ 0.80
Restricted Stock Units (RSU) and Restricted Stock | Minimum                                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                      
Award vesting period                                 3 years    
Performance Shares (PSAs)                                      
Number of Shares                                      
Granted (in shares)                                 1.4    
Performance Shares (PSAs) | Minimum                                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                      
Award vesting period                                 1 year    
Performance Shares (PSAs) | Maximum                                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                      
Award vesting period                                 3 years    
RSUs, RSAs, and PSAs                                      
Number of Shares                                      
Balance at beginning of period (in shares)               20.2                 20.2    
Granted (in shares)                                 9.6    
Vested (in shares)                                 (7.9)    
Canceled (in shares)                                 (1.7)    
Balance at end of period (in shares)         20.2       20.2               20.2 20.2  
Vested and expected-to-vest RSUs, RSAs and PSAs, Number of Shares (in shares)         17.6                       17.6    
Weighted Average Grant-Date Fair Value per Share                                      
Balance at beginning of period (in dollars per share)               $ 26.78                 $ 26.78    
Granted (in dollars per share)                                 28.88    
Vested (in dollars per share)                                 26.04    
Canceled (in dollars per share)                                 26.37    
Balance at end of period (in dollars per share)         $ 28.10       $ 26.78               28.10 $ 26.78  
Vested and expected-to-vest RSUs, RSAs and PSA, Weighted Average Grant-Date Fair Value per Share (in dollars per share)                                 $ 27.67    
Weighted Average Remaining Contractual Term (In Years)                                 1 year 1 month 6 days  
Vested and expected to vest RSUs, RSAs, and PSAs, Weighted Average Remaining Contractual Term (In Years)                                 1 year 1 month 6 days    
Aggregate Intrinsic Value         $ 593.6                     $ 593.6  
Vested and expected-to-vest RSUs, RSAs and PSA, Aggregate Intrinsic Value                                 $ 518.8    
Weighted-average grant-date fair value, RSUs, RSAs, PSUs granted, assumed or substituted (in dollars per share)                                 $ 28.88 $ 29.62 $ 26.21
Fair value of RSUs, RSAs and PSAs                                 $ 206.8 $ 202.2 $ 184.2
Service-based RSUs                                      
Number of Shares                                      
Granted (in shares)                                 7.8    
Marked-based RSUs                                      
Number of Shares                                      
Granted (in shares)                                 0.4